Medicared For All Logo

Lusine Simonyants in Glendale, California

Home California Glendale

Lusine Simonyants has Pulmonary Disease as her primary medical specialty. Their primary office is: 1511 W Glenoaks Blvd in Glendale, California. There is an additional office location, for a total of two, for Lusine Simonyants that can be viewed further down.

They're a part of the: Southern California Pulmonary And Critical Care Associates, Inc. medical group which has around 4 members. You can call their office at 818-637-2200 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Sorry, her university is not listed and graduated in 1998 (around 26 years of experience). They are listed as doing telehealth appointments.


Lusine Simonyants Office Phone and Directions

Lusine Simonyants
Southern California Pulmonary And Critical Care Associates, Inc.
1511 W Glenoaks Blvd
Glendale, California 91201
818-637-2200


Patient Ratings
Please rate your experience with Lusine Simonyants below to help others make a more informed decision. Thanks!
Current Rating: Loading...

Phone: 818-637-2200


Enter a starting address:


Healthcare Info for Lusine Simonyants

Medical School: Sorry, her university is not listed
Graduation Year: 1998
The Primary Medical Specialty for Lusine Simonyants is listed as: Pulmonary Disease
Approximate Years of Experience: 26
PAC (PECOS ID)#: 4385702547
NPI #: 1669685111
NPI Created On: 05/08/2007
NPI Last Updated Listed as: 10/04/2017
Primary Taxonomy Code: 207R00000X
License Number:
A104434
Listed Gender: Female

Procedures, Services, Charges


Services and Procedures include:

  1. X-ray of chest, 2 views
  2. Measurement and graphic recording of the amount and speed of breathed air, before and following medication administration
  3. Test for exercise-induced lung stress
  4. Respiratory inhaled pressure or nonpressure treatment to relieve airway obstruction or for sputum specimen
  5. Demonstration and/or evaluation of patient use of aerosol generator, nebulizer, metered dose inhaler or intermittent positive pressure breathing (ippb) device
  6. Determination of lung volumes using plethysmography
  7. Measurement of lung diffusing capacity
  8. New patient office or other outpatient visit, typically 45 minutes
  9. Established patient office or other outpatient visit, typically 15 minutes
  10. Established patient office or other outpatient, visit typically 25 minutes
  11. Initial hospital inpatient care, typically 70 minutes per day
  12. Subsequent hospital inpatient care, typically 25 minutes per day
  13. Subsequent hospital inpatient care, typically 35 minutes per day
  14. Critical care delivery critically ill or injured patient, first 30-74 minutes
  15. Physician telephone patient service, 11-20 minutes of medical discussion
  16. Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme

They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.


Payments Total: $15

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788545291

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular & Metabolism

Name of Drug #1: XARELTO

Open Associated Drug #1: 50458-580-30


Payments Total: $20

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 796046699

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ANTI-INFECTIVE

Name of Drug #1: DALVANCE

Open Associated Drug #1: 57970-100-01


Payments Total: $15

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 796046701

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ANTI-INFECTIVE

Name of Drug #1: DALVANCE

Open Associated Drug #1: 57970-100-01


Payments Total: $16

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 796046703

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ANTI-INFECTIVE

Name of Drug #1: AVYCAZ

Open Associated Drug #1: 0456-2700-10


Payments Total: $21

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 796046705

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ANTI-INFECTIVE

Name of Drug #1: AVYCAZ

Open Associated Drug #1: 0456-2700-10


Payments Total: $19

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 801632669

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: RESPIRATORY

Name of Drug #1: TRELEGY ELLIPTA

Open Associated Drug #1: 0173-0887-14


Payments Total: $17

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 802506565

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: RESPIRATORY

Name of Drug #1: TRELEGY ELLIPTA

Open Associated Drug #1: 0173-0887-14


Payments Total: $20

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 802877563

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: IMMUNOLOGY

Name of Drug #1: NUCALA

Open Associated Drug #1: 0173-0881-01


Payments Total: $22

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 803132095

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: RESPIRATORY

Name of Drug #1: TRELEGY ELLIPTA

Open Associated Drug #1: 0173-0887-14


Payments Total: $15

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 809625647

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: INFLAMMATION AND IMMUNOLOGY

Name of Drug #1: DUPIXENT

Open Associated Drug #1: 0024-5914-01


Additional Office Locations

1. Vista Critical Care Associates Inc
1511 W Glenoaks Blvd
Glendale, CA 91201
Group Members: 10


Enter a starting address:


Pulmonary Disease Professionals in Glendale

1500 S Central Ave
Glendale, CA

1030 S Glendale Ave
Glendale, CA

1511 W Glenoaks Blvd
Glendale, CA
Vista Critical Care Associates Inc

1505 Wilson Ter
Glendale, CA
Altitude Pulmonary And Critical Care Associates

1511 W Glenoaks Blvd
Glendale, CA
Vista Critical Care Associates Inc

1511 W Glenoaks Blvd
Glendale, CA
Southern California Pulmonary And Critical Care Associates, Inc.

Providers in Southern California Pulmonary And Critical Care Associates, Inc.

1.Sevak Aghazaryan

1511 W Glenoaks Blvd
Glendale Ca 91201-1912
Southern California Pulmonary And Critical Care Associates, Inc.
Nurse Practitioner

2.Gayane Mkrtchyan

1511 W Glenoaks Blvd
Glendale Ca 91201-1912
Southern California Pulmonary And Critical Care Associates, Inc.
Nurse Practitioner

3.Saeid Safaee Md

1511 W Glenoaks Blvd
Glendale Ca 91201-1912
Southern California Pulmonary And Critical Care Associates, Inc.
Pulmonary Disease

4.Lusine Simonyants

1511 W Glenoaks Blvd
Glendale Ca 91201-1912
Southern California Pulmonary And Critical Care Associates, Inc.
Pulmonary Disease

View all 4 members of Southern California Pulmonary And Critical Care Associates, Inc. medical group